Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine platform
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:basedOn |
chimpanzee adenovirus vector
|
| gptkbp:clinicalTrialPhase |
Phase 1
Phase 2 Phase 3 |
| gptkbp:developedBy |
gptkb:University_of_Oxford
gptkb:AstraZeneca |
| https://www.w3.org/2000/01/rdf-schema#label |
ChAdOx1 nCoV-19 platform
|
| gptkbp:inducedBy |
immune response
|
| gptkbp:introducedIn |
2020
|
| gptkbp:relatedTo |
gptkb:ChAdOx1_technology
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:SARS-CoV-2_spike_protein
|
| gptkbp:technology |
viral vector vaccine
|
| gptkbp:usedFor |
vaccine
|
| gptkbp:usedIn |
gptkb:Vaxzevria
gptkb:AZD1222 gptkb:Covishield |
| gptkbp:bfsParent |
gptkb:Covishield
|
| gptkbp:bfsLayer |
5
|